| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |